FDA Panel Backs Major Peptides for Compounding. Here’s What You Need to Know

Peptides have become one of the hottest sectors of health, longevity, and injury recovery. Now six of the most popular ones, including BPC-157 and TB-500, have taken a big step toward being legally available from compounding pharmacies.

Compounding pharmacies use legal exemptions to make customized or off-label versions of drugs, often giving patients cheaper access to treatments that are unavailable, unaffordable, or not sold in the exact form they want.

This isn’t technically an FDA “approval”: An FDA advisory committee recommended adding them to a list of ingredients pharmacies may be allowed to use. The agency itself hasn't decided anything yet.

Peptides are short chains of amino acids, the same building blocks as protein. If a protein is a paragraph, a peptide is a sentence. Because they're small, they mostly act as signals: telling cells to repair tissue, dial down inflammation, burn fuel, sleep, or release hormones.

Insulin is a peptide. So is semaglutide/GLP-1’s and Collagen Peptides fit the bill as well.

After a two-day meeting, the FDA's Pharmacy Compounding Advisory Committee voted to add six peptides to the 503A Bulk Drug Substances List, the roster of ingredients traditional compounding pharmacies are permitted to work with when making customized prescriptions.

A seventh, emideltide (often called DSIP), was rejected.

Worth noting: the FDA's own scientists recommended against all seven. Their objections were thin human evidence, uncertainty about what's actually in some products, possible manufacturing impurities, immune-reaction risk, no standardized dosing, and almost no long-term safety data. The panel overruled them anyway. BPC-157 squeaked through 8-6, with one abstention.

Nobody at the FDA declared these peptides safe and effective. Compounded drugs don't get reviewed like approved medications, the agency generally doesn't verify potency, dosing, or manufacturing consistency before they reach patients.

And you can't get them yet. The vote is nonbinding. The FDA still has to formally adopt it, which could take months or longer. Even if it does, these peptides would require a prescription, be prepared for one patient at a time, and remain unapproved drugs, not over-the-counter supplements.

Most of the enthusiasm for BPC-157 (tendons, ligaments, gut) and TB-500 (wound healing, soft tissue, together the so-called "Wolverine stack") comes from animal studies, lab work, clinical anecdote, and a very large pile of internet testimonials. FDA reviewers examining BPC-157 for ulcerative colitis found little human data and concluded it hadn't been shown to work.

In a rat study, BPC-157 helped a torn knee ligament heal stronger and faster than it did without treatment, but this has not yet been proven in humans:

That said, absence of trials isn't the same as evidence of failure. A major trial costs tens to hundreds of millions of dollars, and companies write that check when patents let them earn it back. Molecules your body already makes are hard to patent.

Restricting compounding didn't end peptide use. It moved it to grey-market websites selling Chinese vials stamped "for research use only." Buyers have essentially no way to confirm what's in the vial, whether the dose is accurate, whether it's sterile, or how it was shipped.

So the pro-access argument is basically harm reduction: people are doing this regardless, and a licensed pharmacy with testing requirements and a prescribing clinician beats an anonymous overseas vendor. The politics line up, too, HHS Secretary Robert F. Kennedy Jr. has spoken favorably about peptides and criticized rules he says push consumers toward unsafe imports.

An FDA advisory panel recommended creating a legal path for licensed pharmacies to compound six popular peptides. That's a genuine shift in philosophy: less "has this cleared the approval bar," more "is supervised access safer than the gray market?"

Supporters see harm reduction. Critics see mass adoption running ahead of the science.

Skip the app store and subscribe directly through Seed Oil Scout for just $19.99/year. Get full access for less and start finding seed oil–free restaurants today.

Join now!

Did you like this newsletter?
Loved it! ❤️
It could be better. 👎

Seed Oil Scout subscriptions keep this newsletter afloat! Get unlimited access to clean dining globally for a deep discount of $19.99 when you join here